OCGN Trading Analysis - 11/05/2026 11:29 AM โ€” TRU-SENTIMENT

OCGN (Ocugen Inc. Common Stock) at $0.82. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $720 vs put $0. RSI 54.7.

TRU-SENTIMENT ยท DeltaNeutral

OCGN Trading Analysis - 11/05/2026 11:29 AM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

OCGN (Ocugen Inc. Common Stock) at $0.82. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $720 vs put $0. RSI 54.7.

Symbol
OCGN
Price
$0.82
Article bias (separate from True Sentiment)
neutral
Conviction
low
Published
2026-11-05 11:29:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

From the embedded True Sentiment options data:

Call Volume: $720.00 (100.00%) Put Volume: $0.00 (0.00%) Total: $720.00

  • Sentiment is Bullish with 24 call contracts vs 0 put contracts, 3 call trades, 0 put trades.
  • Pure directional conviction (Delta 40-60 filter) shows 100% call dollar volume, but only 3 of 88 total options met the filter (3.4%).
  • Near-term expectations lean bullish per options flow, yet the spread recommender notes divergence: technicals show no clear direction.
  • Notable divergence: bullish sentiment vs MACD negative and price below SMA 50.
Note: Options flow shows 100% call conviction in the Delta 40-60 subset, but sample is tiny ($720 total).

Key Statistics: OCGN

$0.81 -3.73%
52-Week Range
$0.69 - $2.73
Market Cap
$276.00M
P/E (TTM)
2.30
PEG Ratio
N/A
Beta
2.31
Next Earnings
N/A
Avg Volume
$5.56M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)2.30
EPS (trailing 12 mo)$-0.26
Market cap$276.00M
Shares outstanding339.1M

Dividend

Dividend yield0.00%

Risk & range

Beta2.31
52-week low$0.69
52-week high$2.73
Historical volatility76.0%

Ownership & trading

Institutional ownership26.7%
Average daily volume7.2M sh

Reported figures; no analyst estimates.


๐Ÿ“ˆ Analysis

News Headlines & Context

The following items are based on general knowledge and are separated from the data-driven sections below.

  • Ocugen (OCGN) continues to advance its COVID-19 booster and rare eye-disease pipeline; recent partner updates on international vaccine rollouts have kept speculative interest elevated.
  • Company presented at a recent biotech investor conference, highlighting progress on itsModifier gene therapy programs, a typical catalyst for retail momentum.
  • No confirmed near-term earnings date in this context, but historical December fiscal-year-end implies updated financials could arrive in early 2027.
  • Biotech sector remains sensitive to FDA commentary and funding headlines, which may amplify OCGN's already high beta of 2.31.
  • Context: Headlines skew constructive, which loosely matches the embedded bullish options sentiment, though technicals remain inconclusive.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data:

  • Trailing P/E is listed at 2.30, but trailing EPS is negative at -0.26, indicating the P/E is not meaningful for profitability assessment.
  • Forward P/E, PEG ratio, price-to-book, total revenue, revenue growth, profit margins, ROE, and debt-to-equity are all null/unavailable in the data.
  • Market cap is $276.00M with shares outstanding of 339.11M and institutional ownership at 26.71%.
  • Beta is 2.31 and historical volatility is 75.95%, reflecting an elevated-risk small-cap biotech profile.
  • 52-week range is $0.69 to $2.73; current price near $0.85 sits in the lower third of that range.
  • No analyst consensus or target price is provided (recommendation key and target mean price are null).
  • Fundamentals show a loss-making micro-cap with no disclosed cash-flow or margin data, which diverges from the bullish options sentiment and neutral technicals.

Current Market Position

Current price from indicators is $0.85 (calculated 2026-11-05). Daily history shows 2026-11-04 close at $0.85 with a range of $0.78โ€“$0.89 on volume of 7,602,829. Minute bars for 2026-11-04 opened at $0.81 and closed near $0.82; by 2026-11-05 11:00 the last bar shows open $0.83, high $0.83, low $0.82, close $0.82. Intraday momentum faded from the 2026-11-04 spike as price drifted from $0.86 (10:40 bar) to $0.82 by 11:00.

Support
$0.78
Resistance
$0.89
20-day SMA
$0.81
Upper Bollinger
$0.96
Lower Bollinger
$0.65

Technical Analysis

Technical Indicators

Current Price
$0.85
SMA 5
$0.75
SMA 20
$0.81
SMA 50
$1.00
RSI 14
54.66
MACD
-0.07
Signal
-0.06
Hist
-0.01
Boll Mid
$0.81
Boll Up
$0.96
Boll Low
$0.65
ATR 14
$0.06

Price is above SMA 5 ($0.75) and SMA 20 ($0.81) but below SMA 50 ($1.00), showing short-term recovery within a longer downtrend. RSI at 54.66 is neutral with slight upward bias. MACD (-0.07) is below signal (-0.06) with negative histogram (-0.01), indicating mild bearish momentum. Bollinger mid is $0.81 with price just above; bands span $0.65โ€“$0.96 (no squeeze signal). 30-day range high $1.12, low $0.69; current $0.85 is roughly 43% up from the low. ATR of $0.06 implies daily movement near 7% of price.

True Sentiment Analysis (Delta 40-60 Options)

From the embedded True Sentiment options data:

Call Volume: $720.00 (100.00%) Put Volume: $0.00 (0.00%) Total: $720.00

  • Sentiment is Bullish with 24 call contracts vs 0 put contracts, 3 call trades, 0 put trades.
  • Pure directional conviction (Delta 40-60 filter) shows 100% call dollar volume, but only 3 of 88 total options met the filter (3.4%).
  • Near-term expectations lean bullish per options flow, yet the spread recommender notes divergence: technicals show no clear direction.
  • Notable divergence: bullish sentiment vs MACD negative and price below SMA 50.
Note: Options flow shows 100% call conviction in the Delta 40-60 subset, but sample is tiny ($720 total).

Key Price Levels (Observational Only)

Daily Low 11-04
$0.78
Daily High 11-04
$0.89
SMA 20
$0.81
SMA 50
$1.00
Boll Lower
$0.65
Boll Upper
$0.96

Interactive charts load with JavaScript. This text is the crawlable summary.